Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.

Study shows boosting diet with supplements could halt prostate tumour growth and help men avoid unnecessary surgery, chemo or radiotherapy ...

SGLT2 inhibitors linked to lower hormone therapy failure in prostate cancer. Learn more about their potential role in improving treatment outcomes.

Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...

The addition of a Lactobacillus probiotic supplement to the phytochemical-rich food supplement significantly improved rate of PSA progression from 23.2% to -21.4% (44.6% change, P 0.001), compared to ...

Add Yahoo as a preferred source to see more of our stories on Google. For men facing the return of prostate cancer, a new combination therapy may offer a much longer break before the disease comes ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...